Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline deepens its commitment to 'electroceuticals'
Fierce Biotech
Tuesday, September 30, 2014 - 11:19am
tags:
GSK, electroceuticals, R&D
ESMO: The latest skinny on drugs from Pfizer, Novartis, GSK, Merck, BMS
Fierce Pharma
Tuesday, September 30, 2014 - 10:08am
tags:
ESMO, Pfizer, Novartis, GSK, Merck, Bristol-Myers Squibb
Allergan buy Salix? Not so fast, say investors intent on Valeant vote
Fierce Pharma
Tuesday, September 30, 2014 - 10:08am
tags:
Allergan, Valeant Pharmaceuticals, M&A, Salix
Does the Open Payments Database ‘Distort’ What Docs Get For Research?
WSJ Pharmalot
Tuesday, September 30, 2014 - 9:58am
tags:
physician payments, Physician Payment Sunshine Act
How Will Johnson & Johnson (JNJ) Stock Be Affected by This Acquisition?
TheStreet.com
Tuesday, September 30, 2014 - 9:57am
tags:
JNJ, M&A, Alios BioPharma
Johnson & Johnson Announces Agreement To Acquire Alios BioPharma
Marketwatch
Tuesday, September 30, 2014 - 8:47am
tags:
JNJ, M&A, Alios BioPharma
Valeant Pharmaceuticals sees third-quarter sales boost
Yahoo/Reuters
Tuesday, September 30, 2014 - 8:43am
tags:
Valeant Pharmaceuticals
Sanofi posts positive results for drug in chronic sinusitis
Yahoo/Reuters
Tuesday, September 30, 2014 - 8:41am
tags:
Sanofi, chronic sinusitis, Regeneron, dupilumab
Medical Devices Lack Safety Evidence, Study Finds
WSJ Online
Tuesday, September 30, 2014 - 8:39am
tags:
devices, safety
Medtronic-Covidien Megamerger May Fall Apart
Bidness Etc.
Tuesday, September 30, 2014 - 8:37am
tags:
Medtronic, Covidien, M&A, devices
Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign targeting women
Yahoo/AP
Tuesday, September 30, 2014 - 8:36am
tags:
Pfizer, Viagra, drug ads
AbbVie Tell Shire Employees: The Merger Will Go On
WSJ Online
Monday, September 29, 2014 - 8:14pm
tags:
AbbVie, Shire, M&A
FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
Monday, September 29, 2014 - 2:00pm
tags:
FDA, Xolair, asthma, Roche, Genentech
Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien
Mass Device
Monday, September 29, 2014 - 1:55pm
tags:
pSivida, Alimera, FDA, devices, Iluvien, diabetic macular edema
Is Ambit Biosciences Getting Enough in Its Buyout?
Yahoo/24-7 Wall St
Monday, September 29, 2014 - 1:53pm
tags:
M&A, Ambit Biosciences, Daiichi Sankyo
Five Reasons Celgene Could Gain 20%
Barron's
Monday, September 29, 2014 - 1:52pm
tags:
Celgene, Actavis
Clovis Shares Higher on Improved Outlook for Lung Cancer Drug
TheStreet.com
Monday, September 29, 2014 - 1:50pm
tags:
Clovis Oncology, lung cancer, AZD9291, rociletinib
MicroBiome Therapeutics' Drug May Limit Metformin Side Effects
Drug Discovery and Development
Monday, September 29, 2014 - 1:18pm
tags:
MicroBiome Therapeutics, diabetes, metformin, NM505
Novo Nordisk Establishes New Obesity Research Unit
Drug Discovery and Development
Monday, September 29, 2014 - 1:17pm
tags:
Novo Nordisk, obesity, R&D
Pharma Events To Watch Out For This Week
Bidness Etc.
Monday, September 29, 2014 - 1:15pm
tags:
Salix, Progenics, Relistor, AASLD, Merck, Gilead Sciences, AbbVie, Intercept Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.